Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 210 publications
The LURN Urinary Urgency and Lifestyle Wearable Tracker (ULTra) study: Design and feasibility.
Journal: Continence (Amsterdam, Netherlands)
Published: August 06, 2026
Integrated Genetic Risk Stratification Identifies High Adenoma Detection Rates at Colonoscopy in a Real-World US Health System.
Journal: Gastro hep advances
Published: May 20, 2026
Unified genetic risk score for prostate cancer enables improved risk stratification for clinical decision-making.
Journal: Journal of medical genetics
Published: May 14, 2026
Symptoms and subtypes of patients with lower urinary tract dysfunction - insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network.
Journal: Nature reviews. Urology
Published: May 01, 2026
Development of an Integrated Monogenic and Polygenic Risk Assessment Tool for Coronary Artery Disease and Its Application in a Community-Based Health Care Biobank.
Journal: Circulation. Genomic and precision medicine
Published: April 10, 2026
Germline genetic risk and prostate cancer-specific mortality in a population-based incident cohort.
Journal: Prostate cancer and prostatic diseases
Published: March 05, 2026
Prostate Cancer, Genetic Susceptibility, and Risk of Chronic Non-Urological Complications.
Journal: The Prostate
Published: February 20, 2026
DGAT1 as a Racially Divergent Driver of Carcinoma-Associated Fibroblast Activation Drives Tumorigenic Pathways via ERK1/2 Signaling in Prostate Cancer.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database.
Journal: BJUI compass
Published: November 17, 2025
Risk for coronary artery disease among individuals with normal low-density lipoprotein cholesterol (LDL-C) levels.
Journal: International journal of cardiology. Cardiovascular risk and prevention
Published: November 14, 2025
DGAT1 Drives Racially Divergent Fibroblast Activation via ERK1/2-Dependent Tumorigenic Signaling in Prostate Cancer.
Journal: Cancer research communications
Published: November 10, 2025
Last Updated: 09/26/2026